Skip to main content

Table 2 cTnI Values and the AICS Clinical Decision: Arm-2

From: Beckman Access versus the Bayer ACS:180 and the Abbott AxSYM cardiac Troponin-I real-time immunoassays: an observational prospective study

BA cTnI Value1 AX cTnI Value2 AICS Present # of Samples AICS Not Present # of Samples
Negative Negative 0 4
Negative Indeterminate 0 1
Negative Positive 0 0
Indeterminate Negative 6 22
Indeterminate Indeterminate 0 4
Indeterminate Positive 2 1
Positive Negative 2 10
Positive Indeterminate 0 2
Positive Positive 38 2
  1. 1 BA Assay: negative <0.03 ng/ml, indeterminate = 0.03–0.15 ng/ml, positive >0.15 ng/ml 2 AX Assay: negative <0.40 ng/ml, indeterminate = 0.40–1.90 ng/ml, positive >1.90 ng/ml